Erschienen in:
01.10.2006 | Original Paper
Topical bioavailability of triamcinolone acetonide: effect of dose and application frequency
verfasst von:
Carolina Pellanda, Evelyne Ottiker, Christoph Strub, Verena Figueiredo, Theo Rufli, Georgios Imanidis, Christian Surber
Erschienen in:
Archives of Dermatological Research
|
Ausgabe 5/2006
Einloggen, um Zugang zu erhalten
Abstract
The application frequency of topical corticosteroids is a recurrently debated topic. Multiple-daily applications are common, although a superior efficacy compared to once-daily application is not unequivocally proven. Only few pharmacokinetic studies investigating application frequency exist. The aim of the study was to investigate the effect of dose (Experiment 1) and application frequency (Experiment 2) on the penetration of triamcinolone acetonide (TACA) into human stratum corneum (SC) in vivo. The experiments were conducted on the forearms of 15 healthy volunteers. In Experiment 1, single TACA doses (300 μg/cm2 and 100 μg/cm2) dissolved in acetone were applied on three sites per arm. In experiment 2, single (1 × 300 μg/cm2) and multiple (3 × 100 μg/cm2) TACA doses were similarly applied. SC samples were harvested by tape stripping after 0.5, 4 and 24 h (Experiment 1) and after 4, 8 and 24 h (Experiment 2). Corneocytes and TACA were quantified by UV/VIS spectroscopy and HPLC, respectively. TACA amounts penetrated into SC were statistically evaluated by a paired-sample t-test. In Experiment 1, TACA amounts within SC after application of 1 × 300 μg/cm2 compared to 1 × 100 μg/cm2 were only significantly different directly after application and similar at 4 and 24 h. In Experiment 2, multiple applications of 3×100 μg/cm2 yielded higher TACA amounts compared to a single application of 1 × 300 μg/cm2 at 4 and 8 h. At 24 h, no difference was observed. In conclusion, using this simple vehicle, considerable TACA amounts were retained within SC independently of dose and application frequency. A low TACA dose applied once should be preferred to a high dose, which may promote higher systemic exposure.